ArticleJournal of nuclear medicine technology2025
UAB/SNMMI Nuclear Medicine Therapy Intensive: Advancing Competence and Innovation in Radiopharmaceutical Therapy.
Article in Journal of nuclear medicine technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Process-Related Incidents in Nuclear Medicine: A Four-Year Single-Center Retrospective Analysis to Support the Implementation of a Scenario-Based Radiopharmacy Training.Pharmacy (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of radiopharmaceutical therapy, fueled by new radiopharmaceuticals approved by the Food and Drug Administration and novel theranostic approaches, has created an urgent demand for advanced training beyond foundational nuclear medicine education. To address this gap, the University of Alabama at Birmingham and the Society of Nuclear Medicine and Molecular Imaging launched the Nuclear Medicine Therapy Intensive in 2024. Designed for practicing nuclear medicine technologists and nuclear medicine advanced associates, this program integrates didactic instruction, simulation-based learning, interprofessional collaboration, and innovative capstone experiences (e.g., a nuclear medicine therapy escape room). Participants engage in activities that strengthen their knowledge in radiation safety, dosimetry, patient eligibility, communication, and clinical trial literacy while applying skills in hands-on therapy simulations. Preassessment and postassessment results from 2024 and 2025 cohorts demonstrated marked gains in knowledge and confidence, with most graduates directly working with theranostics services at their institutions. The weeklong intensive serves as a model for preparing professionals to deliver radiopharmaceutical therapies safely and effectively and with patient-centered excellence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.